ADJUVANT ORAL RAZOXANE (ICRF-159) IN RESECTABLE COLORECTAL-CANCER

被引：0
|
作者：
GILBERT, JM
HELLMANN, K
EVANS, M
CASSELL, PG
STOODLEY, B
ELLIS, H
WASTELL, C
机构：
[1] WEXHAM PK HOSP,SLOUGH,ENGLAND
[2] WESTMINSTER HOSP,LONDON SW1P 2AP,ENGLAND
[3] IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND
[4] EASTBOURNE DIST HOSP,EASTBOURNE,ENGLAND
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：293 / 299
页数：7
相关论文
共 50 条
  • [1] ADJUVANT ORAL RAZOXANE (ICRF 159) IN RESECTABLE COLORECTAL-CANCER
    GILBERT, JM
    HELLMAN, K
    EVANS, M
    CASSELL, PG
    STOODLEY, B
    ELLIS, H
    WASTELL, C
    BRITISH JOURNAL OF SURGERY, 1982, 69 (05) : 282 - 282
  • [2] ADJUVANT ORAL RAZOXANE (ICRF-159) IN RESECTABLE COLO-RECTAL CANCER
    SLEVIN, ML
    HARVEY, VJ
    WRIGLEY, PFM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 10 (03) : 228 - 228
  • [3] INHIBITION OF EXPERIMENTAL COLORECTAL-CANCER BY RAZOXANE (ICRF-159)
    GILBERT, JM
    THOMPSON, EM
    SLAVIN, G
    KARK, AE
    BRITISH JOURNAL OF SURGERY, 1984, 71 (08) : 600 - 603
  • [4] RANDOMIZED TRIAL OF ORAL ADJUVANT RAZOXANE (ICRF-159) IN RESECTABLE COLORECTAL-CANCER - 5-YEAR FOLLOW-UP
    GILBERT, JM
    HELLMANN, K
    EVANS, M
    CASSELL, PG
    TAYLOR, RH
    STOODLEY, B
    ELLIS, H
    WASTELL, C
    BRITISH JOURNAL OF SURGERY, 1986, 73 (06) : 446 - 450
  • [5] ADJUVANT ORAL RAZOXANE (ICRF-159) IN RESECTABLE COLO-RECTAL CANCER - REPLY
    GILBERT, JM
    HELLMANN, K
    EVANS, M
    CASSELL, PG
    STOODLEY, B
    ELLIS, H
    WASTELL, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 10 (03) : 229 - 229
  • [6] CONTROLLED TRIAL OF ORAL ADJUVANT RAZOXANE (ICRF 159) IN COLORECTAL-CANCER
    GILBERT, JM
    HELLMAN, K
    EVANS, M
    CASSELL, PG
    DISEASES OF THE COLON & RECTUM, 1984, 27 (08) : 572 - 572
  • [7] RANDOMIZED TRIAL OF ORAL ADJUVANT RAZOXANE (ICRF159) IN RESECTABLE COLORECTAL-CANCER - 5-YEAR FOLLOW-UP
    HELLMANN, K
    GILBERT, J
    EVANS, M
    CASSELL, P
    TAYLOR, R
    STOODLEY, B
    ELLIS, H
    WASTELL, C
    CLINICAL & EXPERIMENTAL METASTASIS, 1986, 4 (04) : 326 - 326
  • [8] INHIBITION OF EXPERIMENTAL COLORECTAL-CANCER BY RAZOXANE (ICRF159)
    GILBERT, JM
    THOMPSON, EM
    SLAVIN, G
    KARK, AE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 313 - 313
  • [9] RAZOXANE (ICRF-159) IN THE TREATMENT OF PSORIASIS
    ATHERTON, DJ
    WELLS, RS
    LAURENT, MR
    WILLIAMS, YF
    BRITISH JOURNAL OF DERMATOLOGY, 1980, 102 (03) : 307 - 317
  • [10] RAZOXANE (ICRF-159) DELAYS APPEARANCE OF COLORECTAL LIVER METASTASES
    TAYLOR, RH
    GILBERT, JM
    EVANS, MGC
    LANE, HG
    GUT, 1985, 26 (05) : A572 - A572
12345